Chemours annual debt-to-equity ratio
2014
2015
2016
2017
2018
2019
2020
2021
2022
2023
2024
2025
Chemours Debt-to-Equity Ratio Growth & History (CC)
Chemours's debt-to-equity ratio was 17.73 for fiscal 2025.
View full Chemours company overviewChemours annual debt-to-equity ratio history
| Fiscal year | Period ended | Debt-to-equity ratio | Change | Growth |
|---|---|---|---|---|
| 2025 | 2025-12-31 | 17.73 | 10.01 | +129.54% |
| 2024 | 2024-12-31 | 7.73 | 1.68 | +27.78% |
| 2023 | 2023-12-31 | 6.05 | 2.49 | +69.82% |
| 2022 | 2022-12-31 | 3.56 | −0.19 | −5.19% |
| 2021 | 2021-12-31 | 3.75 | −1.60 | −29.84% |
| 2020 | 2020-12-31 | 5.35 | −1.22 | −18.60% |
| 2019 | 2019-12-31 | 6.57 | 2.66 | +67.76% |
| 2018 | 2018-12-31 | 3.92 | −0.87 | −18.09% |
| 2017 | 2017-12-31 | 4.78 | −30.69 | −86.51% |
| 2016 | 2016-12-31 | 35.47 | 4.09 | +13.03% |
| 2015 | 2015-12-31 | 31.38 | 31.38 | — |
| 2014 | 2014-12-31 | 0.00 | — | — |
Chemours quarterly debt-to-equity ratio
Q4.14
Q2.15
Q3.15
Q4.15
Q1.16
Q2.16
Q3.16
Q4.16
Q1.17
Q2.17
Q3.17
Q4.17
Q1.18
Q2.18
Q3.18
Q4.18
Q1.19
Q2.19
Q3.19
Q4.19
Q1.20
Q2.20
Q3.20
Q4.20
Q1.21
Q2.21
Q3.21
Q4.21
Q1.22
Q2.22
Q3.22
Q4.22
Q1.23
Q2.23
Q3.23
Q4.23
Q1.24
Q2.24
Q3.24
Q4.24
Q1.25
Q2.25
Q3.25
Q4.25
Q1.26
| Fiscal quarter | Period ended | Debt-to-equity ratio | Change | YoY change |
|---|---|---|---|---|
| Q1 2026 | 2026-03-31 | 20.59 | 12.77 | +163.37% |
| Q4 2025 | 2025-12-31 | 17.73 | 10.01 | +129.54% |
| Q3 2025 | 2025-09-30 | 16.25 | 9.50 | +140.89% |
| Q2 2025 | 2025-06-30 | 19.51 | 13.50 | +224.92% |
| Q1 2025 | 2025-03-31 | 7.82 | 2.09 | +36.43% |
| Q4 2024 | 2024-12-31 | 7.73 | 1.68 | +27.78% |
| Q3 2024 | 2024-09-30 | 6.74 | 1.05 | +18.54% |
| Q2 2024 | 2024-06-30 | 6.00 | 1.11 | +22.79% |
| Q1 2024 | 2024-03-31 | 5.73 | 2.51 | +77.87% |
| Q4 2023 | 2023-12-31 | 6.05 | 2.49 | +69.82% |
| Q3 2023 | 2023-09-30 | 5.69 | 2.70 | +90.36% |
| Q2 2023 | 2023-06-30 | 4.89 | 1.61 | +49.30% |
| Q1 2023 | 2023-03-31 | 3.22 | −0.23 | −6.65% |
| Q4 2022 | 2022-12-31 | 3.56 | −0.19 | −5.19% |
| Q3 2022 | 2022-09-30 | 2.99 | −1.18 | −28.31% |
| Q2 2022 | 2022-06-30 | 3.28 | −1.53 | −31.90% |
| Q1 2022 | 2022-03-31 | 3.45 | −1.63 | −32.03% |
| Q4 2021 | 2021-12-31 | 3.75 | −1.60 | −29.84% |
| Q3 2021 | 2021-09-30 | 4.17 | −1.89 | −31.23% |
| Q2 2021 | 2021-06-30 | 4.81 | −2.33 | −32.67% |
| Q1 2021 | 2021-03-31 | 5.08 | −1.63 | −24.27% |
| Q4 2020 | 2020-12-31 | 5.35 | −1.22 | −18.60% |
| Q3 2020 | 2020-09-30 | 6.06 | 0.64 | +11.73% |
| Q2 2020 | 2020-06-30 | 7.14 | 1.54 | +27.49% |
| Q1 2020 | 2020-03-31 | 6.70 | 1.37 | +25.67% |
| Q4 2019 | 2019-12-31 | 6.57 | 2.66 | +67.76% |
| Q3 2019 | 2019-09-30 | 5.43 | 1.92 | +54.62% |
| Q2 2019 | 2019-06-30 | 5.60 | 1.70 | +43.63% |
| Q1 2019 | 2019-03-31 | 5.33 | 1.17 | +27.94% |
| Q4 2018 | 2018-12-31 | 3.92 | −0.87 | −18.09% |
| Q3 2018 | 2018-09-30 | 3.51 | −1.61 | −31.49% |
| Q2 2018 | 2018-06-30 | 3.90 | −3.28 | −45.70% |
| Q1 2018 | 2018-03-31 | 4.17 | −5.90 | −58.60% |
| Q4 2017 | 2017-12-31 | 4.78 | −30.69 | −86.51% |
| Q3 2017 | 2017-09-30 | 5.12 | −4.81 | −48.43% |
| Q2 2017 | 2017-06-30 | 7.18 | −16.20 | −69.29% |
| Q1 2017 | 2017-03-31 | 10.07 | −10.96 | −52.12% |
| Q4 2016 | 2016-12-31 | 35.47 | 4.09 | +13.03% |
| Q3 2016 | 2016-09-30 | 9.93 | −36.14 | −78.44% |
| Q2 2016 | 2016-06-30 | 23.39 | 13.55 | +137.85% |
| Q1 2016 | 2016-03-31 | 21.03 | — | — |
| Q4 2015 | 2015-12-31 | 31.38 | 31.38 | — |
| Q3 2015 | 2015-09-30 | 46.07 | — | — |
| Q2 2015 | 2015-06-30 | 9.83 | — | — |
| Q4 2014 | 2014-12-31 | 0.00 | — | — |
Chemours debt-to-equity ratio trends
Over the last five fiscal years, Chemours's debt-to-equity ratio increased from 5.35 to 17.73, a change of 12.38. The latest reported quarter, Q1 2026, shows 20.59.
About the metric
What the debt-to-equity ratio means
The debt-to-equity ratio compares interest-bearing debt with shareholders’ equity. It helps show how much debt financing a company uses relative to its accounting equity, but useful comparison levels vary by industry.
Calculation and source
How debt-to-equity is calculated
TickerStat calculates debt-to-equity as total interest-bearing debt divided by SEC-reported shareholders’ equity for the same balance-sheet date. Total liabilities are not treated as debt, and periods with non-positive equity are omitted. Fiscal periods can differ from calendar years, so exact period-end dates are included.
Review Chemours source filings ↗Community posts
Chemours, DuPont and Corteva agree to a $455 million PFAS settlement
Chemours ($CC), DuPont ($DD) and Corteva ($CTVA) reached an agreement to resolve PFAS-related claims brought by North Carolina and 11 local government entities. The settlement provides for $455 million in nominal payments over 15 years. Che ...